Sign in
AVRO Stock Price, Chart, Stats & News
AVROBIO, Inc.
Save
5.24M
Market cap
0.17x
Current P/E
–
Forward P/E
AVRO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 1.69% |
ROA | -28.41% |
ROE | -26.87% |
D/E | 0.01x |
Interest coverage ratio | -509.31x |
AVRO valuation
P/E | 0.17x |
P/S | – |
P/B | 0.10x |
P/CF | -0.43x |
P/FCF | -0.09x |
P/OCF | -0.43x |
PEG | -0.01x |
EV multiple | -3.31x |
About
AVROBIO, Inc. is a biotechnology firm in the clinical development stage, dedicated to advancing gene therapies. The company specializes in an ex vivo lentiviral-based approach, aiming to address rare genetic conditions worldwide through a single therapeutic administration. Their innovative methodology involves collecting hematopoietic stem cells directly from patients.
Similar securities
Based on sector and market capitalization
Report issue